Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 3740 | 39.31 |
09:34 ET | 547 | 39.3519 |
09:36 ET | 300 | 38.98 |
09:38 ET | 3245 | 38.91 |
09:39 ET | 2781 | 39.1 |
09:41 ET | 830 | 39.41 |
09:43 ET | 1000 | 39.675 |
09:45 ET | 576 | 39.65 |
09:48 ET | 1670 | 39.51 |
09:50 ET | 1728 | 39.42 |
09:52 ET | 1326 | 39.505 |
09:54 ET | 2050 | 39.48 |
09:56 ET | 1145 | 39.63 |
09:57 ET | 1773 | 39.98 |
09:59 ET | 1280 | 39.95 |
10:01 ET | 2508 | 39.8 |
10:03 ET | 3940 | 39.485 |
10:06 ET | 2197 | 39.435 |
10:08 ET | 1266 | 39.42 |
10:10 ET | 8025 | 39.35 |
10:12 ET | 3912 | 39.21 |
10:14 ET | 700 | 39.38 |
10:15 ET | 200 | 39.275 |
10:17 ET | 795 | 38.98 |
10:19 ET | 100 | 38.85 |
10:21 ET | 400 | 38.88 |
10:24 ET | 100 | 38.98 |
10:26 ET | 4205 | 38.975 |
10:28 ET | 14135 | 39 |
10:30 ET | 3508 | 39.015 |
10:32 ET | 4040 | 39 |
10:33 ET | 905 | 38.89 |
10:35 ET | 350 | 38.87 |
10:37 ET | 5140 | 38.87 |
10:42 ET | 400 | 38.82 |
10:44 ET | 100 | 38.86 |
10:46 ET | 900 | 38.78 |
10:48 ET | 200 | 38.79 |
10:50 ET | 605 | 38.82 |
10:51 ET | 3131 | 38.5 |
10:53 ET | 1400 | 38.48 |
10:55 ET | 2938 | 38.345 |
11:00 ET | 1765 | 38.4 |
11:02 ET | 5700 | 38.5127 |
11:04 ET | 1505 | 38.675 |
11:06 ET | 430 | 38.685 |
11:08 ET | 1360 | 38.79 |
11:09 ET | 5600 | 38.82 |
11:11 ET | 100 | 38.82 |
11:13 ET | 1000 | 38.74 |
11:18 ET | 1817 | 38.79 |
11:22 ET | 4312 | 38.39 |
11:24 ET | 430 | 38.4829 |
11:26 ET | 200 | 38.4692 |
11:27 ET | 700 | 38.445 |
11:29 ET | 1070 | 38.4 |
11:31 ET | 340 | 38.35 |
11:33 ET | 2390 | 38.265 |
11:36 ET | 2919 | 38.36 |
11:38 ET | 400 | 38.365 |
11:40 ET | 2053 | 38.35 |
11:42 ET | 4208 | 38.295 |
11:44 ET | 1864 | 38.39 |
11:45 ET | 300 | 38.425 |
11:47 ET | 573 | 38.37 |
11:49 ET | 711 | 38.32 |
11:51 ET | 3395 | 38.18 |
11:54 ET | 523 | 38.13 |
11:56 ET | 6075 | 38.2599 |
11:58 ET | 2825 | 38.29 |
12:00 ET | 2831 | 38.385 |
12:02 ET | 10690 | 38.27 |
12:03 ET | 2265 | 38.26 |
12:05 ET | 1607 | 38.25 |
12:07 ET | 200 | 38.2643 |
12:09 ET | 500 | 38.27 |
12:12 ET | 400 | 38.27 |
12:14 ET | 310 | 38.27 |
12:16 ET | 1000 | 38.275 |
12:18 ET | 200 | 38.275 |
12:20 ET | 700 | 38.29 |
12:21 ET | 2106 | 38.262 |
12:23 ET | 1207 | 38.115 |
12:25 ET | 1458 | 38.095 |
12:27 ET | 563 | 38.095 |
12:30 ET | 2438 | 38.36 |
12:32 ET | 400 | 38.315 |
12:34 ET | 300 | 38.315 |
12:36 ET | 1000 | 38.315 |
12:38 ET | 637 | 38.35 |
12:39 ET | 1200 | 38.21 |
12:41 ET | 1095 | 38.115 |
12:43 ET | 1494 | 38.21 |
12:45 ET | 700 | 38.15 |
12:48 ET | 927 | 38.19 |
12:50 ET | 3796 | 38.35 |
12:52 ET | 1840 | 38.41 |
12:54 ET | 1424 | 38.29 |
12:57 ET | 1207 | 38.285 |
12:59 ET | 100 | 38.245 |
01:01 ET | 300 | 38.245 |
01:03 ET | 350 | 38.29 |
01:06 ET | 400 | 38.245 |
01:08 ET | 900 | 38.285 |
01:10 ET | 635 | 38.25 |
01:12 ET | 2596 | 38.275 |
01:14 ET | 2412 | 38.41 |
01:15 ET | 817 | 38.41 |
01:17 ET | 1300 | 38.51 |
01:19 ET | 1114 | 38.54 |
01:21 ET | 838 | 38.475 |
01:24 ET | 484 | 38.475 |
01:26 ET | 1700 | 38.54 |
01:28 ET | 1320 | 38.62 |
01:30 ET | 700 | 38.565 |
01:32 ET | 4343 | 38.44 |
01:33 ET | 600 | 38.44 |
01:35 ET | 425 | 38.435 |
01:37 ET | 15629 | 38.31 |
01:39 ET | 700 | 38.27 |
01:42 ET | 2150 | 38.4749 |
01:44 ET | 3261 | 38.82 |
01:46 ET | 1714 | 38.71 |
01:48 ET | 300 | 38.69 |
01:50 ET | 100 | 38.705 |
01:51 ET | 3474 | 38.755 |
01:53 ET | 712 | 38.77 |
01:55 ET | 300 | 38.79 |
01:57 ET | 100 | 38.77 |
02:00 ET | 2777 | 38.73 |
02:02 ET | 2720 | 38.85 |
02:04 ET | 1918 | 39.015 |
02:06 ET | 100 | 39.015 |
02:08 ET | 300 | 39.005 |
02:09 ET | 800 | 38.995 |
02:11 ET | 4242 | 38.99 |
02:13 ET | 4378 | 38.965 |
02:15 ET | 400 | 38.965 |
02:18 ET | 4269 | 38.995 |
02:20 ET | 200 | 38.995 |
02:22 ET | 1140 | 38.995 |
02:24 ET | 3461 | 38.97 |
02:26 ET | 700 | 38.99 |
02:27 ET | 5355 | 38.86 |
02:29 ET | 3858 | 38.94 |
02:31 ET | 290 | 39 |
02:33 ET | 200 | 38.945 |
02:36 ET | 1006 | 38.94 |
02:38 ET | 5563 | 38.98 |
02:40 ET | 2433 | 39 |
02:42 ET | 7843 | 38.95 |
02:44 ET | 3348 | 38.915 |
02:45 ET | 900 | 38.91 |
02:47 ET | 1138 | 38.66 |
02:49 ET | 2361 | 38.88 |
02:51 ET | 400 | 38.88 |
02:54 ET | 1600 | 38.64 |
02:56 ET | 300 | 38.74 |
02:58 ET | 600 | 38.62 |
03:00 ET | 904 | 38.6 |
03:02 ET | 200 | 38.575 |
03:03 ET | 2279 | 38.67 |
03:05 ET | 762 | 38.61 |
03:07 ET | 100 | 38.605 |
03:09 ET | 3038 | 38.66 |
03:12 ET | 1378 | 38.73 |
03:14 ET | 631 | 38.73 |
03:16 ET | 400 | 38.735 |
03:18 ET | 1259 | 38.7 |
03:20 ET | 1999 | 38.77 |
03:21 ET | 2288 | 38.79 |
03:23 ET | 500 | 38.9199 |
03:25 ET | 825 | 38.8 |
03:27 ET | 929 | 38.825 |
03:30 ET | 300 | 38.82 |
03:32 ET | 525 | 38.815 |
03:34 ET | 7892 | 38.735 |
03:36 ET | 852 | 38.725 |
03:38 ET | 2389 | 38.76 |
03:39 ET | 1217 | 38.83 |
03:41 ET | 1915 | 38.71 |
03:43 ET | 2300 | 38.85 |
03:45 ET | 1442 | 38.82 |
03:48 ET | 700 | 38.85 |
03:50 ET | 3320 | 39.03 |
03:52 ET | 19723 | 39 |
03:54 ET | 45164 | 38.83 |
03:56 ET | 8813 | 38.76 |
03:57 ET | 10997 | 38.79 |
03:59 ET | 21306 | 38.73 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.2B | -16.7x | --- |
Apogee Therapeutics Inc | 2.2B | -18.7x | --- |
Iovance Biotherapeutics Inc | 2.2B | -4.3x | --- |
CG Oncology Inc | 2.1B | -27.8x | --- |
Janux Therapeutics Inc | 2.0B | -32.1x | --- |
Geron Corp | 2.5B | -12.0x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -16.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.